Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...

Key research pitching the drugs against each other found Mounjaro was superior when it came to shedding pounds and losing ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

I shed two stone on weight-loss drugs – then got ‘Ozempic tongue’ - COMMENT: Although the drugs help me shift unhealthy ...

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

Weight-loss jab Mounjaro helps people shed significantly more weight than rival Wegovy, new research suggests.

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants ...

Weight-loss drugs will be offered to millions of the most obese people on the NHS, to help them manage their health. Wegovy ...

The U.S. Environmental Protection Agency has drafted a plan to eliminate all limits on greenhouse gases from coal and ...

A major UK study has revealed that older women are getting the best results from weight loss jabs – not from shortcuts, but ...